The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical synergy of universal paired tumor genomic and germline sequencing in an unselected, pan-cancer cohort of patients: Greater than the sum of the parts.
 
Brandie Heald
Employment - InVitae
Stock and Other Ownership Interests - InVitae
 
Sarah M. Nielsen
Employment - InVitae
Stock and Other Ownership Interests - Invitae
Travel, Accommodations, Expenses - Invitae
 
Idara Ekpoh
No Relationships to Disclose
 
Dana Alexander
No Relationships to Disclose
 
Rish Pai
Consulting or Advisory Role - Abbvie; Alimentiv; Allergan
 
Michael A. Golafshar
No Relationships to Disclose
 
Katie Kunze
No Relationships to Disclose
 
Pedro Luiz Serrano Uson Junior
No Relationships to Disclose
 
Tanios S. Bekaii-Saab
Consulting or Advisory Role - Abbvie; Amgen (Inst); Arcus Biosciences (Inst); AstraZeneca; Bayer (Inst); BeiGene; Boehringer Ingelheim; Caladrius Biosciences; Caladrius Biosciences; Celularity; Daiichi Sankyo/UCB Japan; Deciphera; Eisai; Eisai; Exact Sciences; Foundation Medicine; Foundation Medicine; Illumina; Immuneering; Incyte (Inst); Ipsen (Inst); Janssen; Kanaph Therapeutics; Lilly (Inst); Natera; Pfizer (Inst); Roche/Genentech (Inst); Seagen (Inst); SOBI; Stemline Therapeutics; Treos Bio; Zai Lab
Patents, Royalties, Other Intellectual Property - Patent WO/2018/183488; Patent WO/2019/055687
Other Relationship - 1Globe Health Institute; AstraZeneca; Exelixis; FibroGen; Imugene; Lilly; Merck (Inst); Pancreatic Cancer Action Network; Replimune; Sun Biopharma; Suzhou Kintor Pharmaceuticals; UpToDate; Xilis
 
Daniel H. Ahn
Stock and Other Ownership Interests - Natera
Consulting or Advisory Role - Advanced Accelerator Applications; Daiichi Sankyo/Astra Zeneca; Eisai; Exelixis; Genentech/Roche; Incyte; Incyte; Novartis
Research Funding - AstraZeneca; Bayer
 
Christina Wu
Honoraria - Cancer Treament Centers of America; Medscape; Oncology Learning Network; PrecisCA
Consulting or Advisory Role - Array BioPHarma; Daiichi Sankyo/Lilly; Natera; Natera; Nova Research Company; Pfizer; Seagen
Research Funding - Boston Biomedical (Inst); HUTCHMED; InhibRx (Inst); Lycera (Inst); Pfizer; RAPT Therapeutics (Inst); Seagen (Inst); Symphogen (Inst); Vaccinex (Inst)
 
Daniel Esteban Pineda Alvarez
Employment - GeneDx/BioReference (I); InVitae; Variantyx (I)
Stock and Other Ownership Interests - Invitae
 
N. Jewel Samadder
Consulting or Advisory Role - Cancer Prevention Pharmaceuticals; Janssen Research & Development; Recursion Pharmaceuticals
 
Edward D. Esplin
Employment - Invitae
Stock and Other Ownership Interests - Invitae
Consulting or Advisory Role - Taproot Health Inc